Back to
Vontobel Holding Ltd.
PTGX
Showing 0 of 10 quarters
Position history for
Vontobel Holding Ltd.'s holdings in PROTAGONIST THERAPEUTICS INC
No. Vontobel Holding exited its PTGX (Protagonist Therapeutics) position in Q2 2023. Its Q1 2023 13F listed 40,000 shares worth $920,000. Vontobel Holding first reported PTGX in Q1 2021 and held it in 9 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.